The Future of Parkinsons Wellness
- 5 days ago
- 1 min read
Parkinson’s disease (PD) continues to stand as one of the most challenging neurodegenerative conditions of our time, characterized by the progressive loss of dopaminergic neurons within the substantia nigra. Traditional treatment modalities, while effective at managing early symptoms via dopamine replacement, fail to alter the underlying degenerative trajectory of the disease. However, recent paradigms in regenerative medicine are shifting the focus from temporary symptom management to active neuroprotection and tissue restoration.
Among the most promising frontiers is the combination of human Umbilical Cord Tissue Mesenchymal Stem Cells (hUC-MSCs) and MSC-derived exosomes, administered simultaneously through a targeted, dual-route delivery system: Intravenous (IV) infusion and Intrathecal (IT) injection. This comprehensive guide breaks down the clinical efficacy, biological mechanics, and safety profile of this cutting-edge therapeutic synergy.
CALL 239-571-0627 FOR MORE DETAILS AND VISIT OUR WEBSITE AT WWW.INFINITYHEALTH.ZONE
STEM CELL THERAPIES ARE NOT FDA APPROVED
Comments